- Home
- PRZO vs COCP Comparison
PRZO vs COCP Comparison
Compare PRZO & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- COCP
- Stock Information
- Founded
- PRZO 2014
- COCP N/A
- Country
- PRZO Israel
- COCP United States
- Employees
- PRZO N/A
- COCP N/A
- Industry
- PRZO
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- COCP Health Care
- Exchange
- PRZO Nasdaq
- COCP Nasdaq
- Market Cap
- PRZO 13.7M
- COCP 15.3M
- IPO Year
- PRZO 2023
- COCP N/A
- Fundamental
- Price
- PRZO $0.60
- COCP $1.37
- Analyst Decision
- PRZO
- COCP Strong Buy
- Analyst Count
- PRZO 0
- COCP 1
- Target Price
- PRZO N/A
- COCP $7.00
- AVG Volume (30 Days)
- PRZO 340.9K
- COCP 18.6K
- Earning Date
- PRZO 03-21-2025
- COCP 03-31-2025
- Dividend Yield
- PRZO N/A
- COCP N/A
- EPS Growth
- PRZO N/A
- COCP N/A
- EPS
- PRZO N/A
- COCP N/A
- Revenue
- PRZO $932,154.00
- COCP N/A
- Revenue This Year
- PRZO N/A
- COCP N/A
- Revenue Next Year
- PRZO N/A
- COCP N/A
- P/E Ratio
- PRZO N/A
- COCP N/A
- Revenue Growth
- PRZO 50.22
- COCP N/A
- 52 Week Low
- PRZO $0.49
- COCP $1.35
- 52 Week High
- PRZO $3.16
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- PRZO 25.11
- COCP 31.76
- Support Level
- PRZO $0.70
- COCP $1.35
- Resistance Level
- PRZO $0.78
- COCP $1.49
- Average True Range (ATR)
- PRZO 0.08
- COCP 0.09
- MACD
- PRZO -0.00
- COCP -0.00
- Stochastic Oscillator
- PRZO 4.54
- COCP 7.14
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).